Table 16 Comparasion of the Pfizer and AstraZeneca vaccination centers during the post-vaccination process*
From: Vaccination process evaluation at COVID-19 vaccination centers in Lebanon: a national study
Questions | PZ N = 20 (%) | AZ N = 13 (%) | Total vaccine N = 33 (%) | P-value |
|---|---|---|---|---|
1. Patients are being monitored for 15–30 min post-vaccination | ||||
 No | 6 (30.0) | 5 (38.5) | 11 (33.3) | 0.614 |
 Yes | 14 (70.0) | 8 (61.5) | 22 (66.7) | |
2. Counseling and after-care instructions are given at the vaccination site | ||||
 No | 4 (20.0) | 3 (23.1) | 7 (21.2) | 0.637 |
 Yes | 16 (80.0) | 9 (69.2) | 25 (75.8) | |
 Not observed | 0 (0.0) | 1 (7.70) | 1 (3.0) | |
3. Qualified medical team is available to manage any emergencies or serious adverse event following immunization (AEFI) | ||||
 Yes | 20 (100.0) | 13 (100.0) | 33 (100.0) | – |
4. There is a well-equipped designated area at the site for AEFI management | ||||
 No | 4 (20.0) | 2 (15.4) | 6 (18.2) | 1.0 |
 Yes | 16 (80.0) | 11 (84.6) | 27 (81.8) | |